Search results for "pharma and biotech"

Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102, demonstrating potent antitumor...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs

Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs

A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST. More than 20 years ago, the introduction of...
Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise

Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise

Early clinical data point to extended survival and the rare possibility of complete remission in metastatic pancreatic...
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World...
Daewoong Pharmaceutical Acquires U.S. Cellular Reprogramming Tech to Fast-Track Anti-Aging Therapeutics

Daewoong Pharmaceutical Acquires U.S. Cellular Reprogramming Tech to Fast-Track Anti-Aging Therapeutics

Daewoong Pharmaceutical is accelerating its research and development into anti-aging therapeutics.
Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection

Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection

Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection...
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge

K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge

More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.
“Now Is the Golden Time”: Daegu Bets on a Medical Tourism Comeback with ‘K-Beauty’

“Now Is the Golden Time”: Daegu Bets on a Medical Tourism Comeback with ‘K-Beauty’

Daegu, which stood on the front lines of regional healthcare during the COVID-19 pandemic, now faces another turning...
Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?

Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?

A final decision on the approval of RIMQARTO (anbalcabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T)...
Global Competition to Cultivate 'Good Doctors' Transforms Medical Classrooms

Global Competition to Cultivate 'Good Doctors' Transforms Medical Classrooms

From Technical Instruction to Patient-Centered Care“How do you tell a patient they have terminal cancer.